Ceidos

Startup

With the emergence of cell therapies, in particular CAR-T therapies, an ever-increasing number of applications require the use and control of cell cultures. Many steps of this process involve human intervention. Cell counting and viability measurement among others, are performed daily. Each of these interventions significantly increases the risk of contamination as well as the final cost of therapy. Failure due to wrong manipulations or bacterial contamination can be dramatic from the patient perspective. That is why everything must be done to simplify and automate the production.

Ceidos proposes a revolutionary device able to perform automated cell counting and viability measurements in an aseptic way during cell expansion, maintaining the incubator close and safe. 



website